KalVista shareholders elect directors, ratify auditor, approve say-on-pay at 2024 annual meeting

KalVista Pharmaceuticals, Inc.

William Fairey and Nancy Stuart elected as Class III directors with 30.2M and 19.3M votes 'For', respectively; Stuart faced 11.7M votes 'Against'.
Deloitte & Touche ratified as independent auditor for FY ending April 30, 2025 with 39.3M votes 'For'.
Advisory say-on-pay proposal approved with 26.6M 'For', 4.5M 'Against'.
Broker non-votes of 8.3M shares recorded for director election and say-on-pay proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.